Prelude Therapeutics Inc - PRLD

Sector: Healthcare · Industry: Pharmaceutical Preparations

Website: No information yet · Social: No information yet

Company profile

Latest / Compare

Q2 2026 · Q1 2026

Value (USD)

Total reported value ($000)

$265.9M

QoQ value delta ($000)

+$160.7M (+152.59%)

Implied price effect (QoQ)

+55.85%

Total shares

49,906,280

QoQ shares delta

+19,112,864 (+62.07%)

Total shares held by funds (by quarter)

Interactive chart by TradingView.

Top 25 only Full list

Partial Q2 2026 data: 77 holders have filed so far. Prior holders are carried forward until their next 13F confirms a change.

Manager	Value ($000)	Shares	% of 13F
ORBIMED ADVISORS LLC	73,151	13,724,571	1.36%
BAKER BROS. ADVISORS LP	53,959	10,123,824	0.27%
RA CAPITAL MANAGEMENT, L.P.	34,516	6,475,882	0.3%
Soleus Capital Management, L.P.	18,006	3,378,378	0.62%
Kynam Capital Management, LP	12,872	2,415,087	0.71%
VANGUARD CAPITAL MANAGEMENT LLC	10,710	2,009,445	0.0%
BlackRock, Inc.	9,580	1,797,501	0.0%
SPHERA FUNDS MANAGEMENT LTD.	5,435	1,019,832	0.71%
TWO SIGMA INVESTMENTS, LP	5,294	993,369	0.0%
ADAR1 Capital Management, LLC	4,801	900,900	0.22%
MILLENNIUM MANAGEMENT LLC	4,503	844,993	0.0%
GEODE CAPITAL MANAGEMENT, LLC	4,487	841,862	0.0%
ADAGE CAPITAL PARTNERS GP, L.L.C.	4,083	766,095	0.01%
ACADIAN ASSET MANAGEMENT LLC	3,253	611,359	0.0%
MORGAN STANLEY	2,685	503,860	0.0%
STATE STREET CORP	2,285	428,787	0.0%
UBS Group AG	1,699	318,797	0.0%
VANGUARD FIDUCIARY TRUST CO	1,518	284,886	0.0%
RENAISSANCE TECHNOLOGIES LLC	1,498	281,200	0.0%
NORTHERN TRUST CORP	1,282	240,599	0.0%
VANGUARD PORTFOLIO MANAGEMENT LLC	1,033	193,920	0.0%
MARSHALL WACE, LLP	1,016	190,692	0.0%
SUSQUEHANNA INTERNATIONAL GROUP, LLP	931	174,700	0.0%
Connor, Clark & Lunn Investment Management Ltd.	669	125,606	0.0%
GOLDMAN SACHS GROUP INC	644	120,834	0.0%